Their findings suggest that Extracellular ADO amplifies PD-1 expression in CD8 + T cells, triggering all-trans retinoid acid and IFN-β that negatively regulate intra-tumor CD8 + cytotoxic T cells, leading to their exhaustion and subsequent resistance to anti-PD-1 blockage11. The gene discussed is ADO; the disease is neoplasm.